23 May, 2026
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on…
WASHINGTON — A group of Senate Democrats is proposing that Medicare cover in-home care, which would create the first new benefit in the program since the Part D retail drug…
The Trump administration has made sweeping changes to vaccine policy over the past year justified by invocations of patients’ “personal autonomy.” In January, Department of Health and Human Services head…
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Shelley Wood and Eric Topol. Be sure to sign up for the weekly “First Opinion Podcast”…
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on…

Who is involuntary commitment for?

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a […]

11 mins read

Ouster of Vinay Prasad, top FDA official

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. This week’s show is focused […]

1 min read

Kennedy, disability advocates paint different realities as ADA turns 35

Stirring speeches filled the tall, fluorescent room on Monday morning as members of the disability community and federal officials celebrated the 35th anniversary of the passage of the Americans with Disabilities Act. They spoke at length about how the landmark law birthed critical protections and technologies that have helped disabled people flourish, but many communities […]

6 mins read

Sarepta, Eli Lilly, SSRI effects, NIH, Bristol

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ gene therapy, see an FDA panel made up largely of SSRI skeptics lambast their use in […]

2 mins read

Tenet, HCA report Q2 earnings, boost outlook

Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. Two major investor-owned hospital chains upped their 2025 revenue and profit forecasts this week, in stark contrast to health insurers, who’ve been doing the opposite.  HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their […]

1 min read

Trump order threatens supervised consumption, harm reduction

President Trump is threatening to withhold funds from supervised drug consumption sites and potentially pursue criminal penalties against them, offering his clearest stance yet against the philosophy of harm reduction and marking a significant escalation of his rhetoric on substance use and addiction.  The new position, announced in a Thursday executive order, pledged to end […]

7 mins read